| Financial Year |
March 31 2023 |
| Monetary Funds |
244,209,509.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
410,957,042.61 |
| Advances to Suppliers |
83,152,867.55 |
| Other Receivables |
54,109,956.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
105,683,946.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,397,877.79 |
| Total Current Assets |
1,028,022,488.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,519,833.30 |
| Long-term Equity Investment |
-- |
| Investment Properties |
37,067,542.11 |
| Fixed Assetes |
326,873,487.34 |
| Under-construction Projects |
30,592,917.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,057,264.19 |
| R&D expenses |
-- |
| Goodwill |
68,235,281.67 |
| Long-Term Deferred and Prepaid Expenses |
591,319.32 |
| Deferred Income Tax Assets |
10,035,747.98 |
| Other Non-Current Assets |
30,583,309.00 |
| Sub-Total of Non-Current Assets |
915,827,492.15 |
| Total Assets |
1,943,849,980.16 |
| Short-Term Loans |
187,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
137,087,680.61 |
| Accounts Payable |
193,672,526.07 |
| Accounts Received In Advance |
495,000.00 |
| Employee Compensation Payable |
75,810,633.53 |
| Taxes Payable |
-- |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
-- |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,000,000.00 |
| Other Current Liabilities |
3,392,254.45 |
| Sub-Total of Current Liabilities |
694,843,633.93 |
| Long-term Loans |
80,086,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
85,670,407.93 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,465,485.35 |
| Deferred Income Tax Liabilities |
11,502,672.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
205,695,248.88 |
| Total Liabilities |
900,538,882.81 |
| Paid-In Capital(Or Share Stock) |
628,142,564.00 |
| Capital Surplus |
70,143,657.60 |
| Surplus Reserve |
126,357,420.26 |
| LESS:Treasury Stock |
31,691,080.90 |
| Undistributed Profits |
211,873,671.14 |
| Minority Stockholder's Interest |
36,858,689.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,006,452,407.38 |
| Owner's Equity（Stockholder's Equity） |
1,043,311,097.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,943,849,980.16 |
